What is lantidra?: The First FDA-Approved Cell Therapy for Type 1 Diabetes
•
3 min read
In June 2023, the U.S. FDA approved Lantidra, a major milestone as the first allogeneic pancreatic islet cellular therapy for type 1 diabetes. What is lantidra?, and how does this innovative treatment offer hope for adults experiencing debilitating episodes of severe hypoglycemia despite intensive insulin management?.
